Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2018-07-27 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于转让浙江赛尚医药科技有限公司67%股权的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding the progress of the transfer of 67% equity in 浙江赛尚医药科技有限公司. It details the background of the equity transfer agreement, the failure of the counterparty to pay the agreed amount, subsequent commitments, and the company's legal action due to non-payment. The document is an update on a capital transaction and related legal proceedings, but it is not a full financial report, earnings release, or management discussion. It is a specific update on a financing-related event (equity transfer progress and litigation). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on this update, not a report publication or regulatory filing. Confidence is high due to clear content and context.
2018-07-27 Chinese
关于龚虹嘉先生增持公司股份计划实施结果的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholding increase plan by Mr. Gong Hongjia, detailing the number of shares acquired, the percentage of total shares held, and the commitment not to reduce holdings within a specified period. It includes specifics about the share acquisition method and the resulting ownership percentage. This type of document is a notification of a change in significant share ownership levels, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on this shareholding change, with no financial statements or broader company performance data, so it is not an Annual Report or Earnings Release. Therefore, the correct classification is MRQ.
2018-07-23 Chinese
关于子公司协和干细胞基因工程有限公司为公司诉讼财产保全提供担保的解除公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the release of a guarantee provided by a subsidiary for litigation property preservation. It details the guarantee situation, the release of the guarantee, and cumulative external guarantees and overdue guarantees. There is no financial data, no report or presentation attached, and no mention of voting results or management changes. The content is a regulatory announcement about guarantee and collateral matters related to litigation, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like financial reports, earnings, or capital updates.
2018-07-13 Chinese
关于控股股东和龚虹嘉先生增持公司股份计划的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a share increase plan by the controlling shareholder and an individual shareholder. It details the planned share purchases, current holdings, and reasons for delays, but does not contain financial statements or results. It is a disclosure about shareholding changes and intentions to increase shares, fitting the category of Major Shareholding Notification rather than a full financial report or other types of filings.
2018-07-02 Chinese
关于子公司协和干细胞基因工程有限公司为公司诉讼财产保全提供担保的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding a guarantee provided by its subsidiary for litigation property preservation. It details the guarantee amount, the internal decision-making process, the background of the litigation, and the financial status of the company. The document is an announcement of a specific corporate action related to guarantees and litigation, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but rather discloses a corporate guarantee event. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital updates or management changes.
2018-06-29 Chinese
涉及诉讼的公告
Legal Proceedings Report Classification · 100% confidence The document is a public announcement by a company regarding a legal proceeding in which it is involved as a plaintiff. It details the litigation case, including the parties involved, the claims, the amount in dispute, and the current status of the lawsuit. There is no financial report, earnings data, or management discussion. The document is clearly a legal proceeding update and not a financial report or other filing type. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is 1912 characters, which is consistent with a detailed announcement but not a full report like an annual or interim report.
2018-06-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.